MARCHEX INC-CLASS B (MCHX)

US56624R1086 - Common Stock

1.34  +0.04 (+3.08%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to MCHX. MCHX was compared to 96 industry peers in the Media industry. The financial health of MCHX is average, but there are quite some concerns on its profitability. MCHX has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

MCHX had negative earnings in the past year.
MCHX had a negative operating cash flow in the past year.
MCHX had negative earnings in each of the past 5 years.
MCHX had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

MCHX has a worse Return On Assets (-15.10%) than 80.00% of its industry peers.
Looking at the Return On Equity, with a value of -19.75%, MCHX is doing worse than 66.32% of the companies in the same industry.
Industry RankSector Rank
ROA -15.1%
ROE -19.75%
ROIC N/A
ROA(3y)-14%
ROA(5y)-19.03%
ROE(3y)-18.26%
ROE(5y)-26.33%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 60.25%, MCHX is doing good in the industry, outperforming 72.63% of the companies in the same industry.
In the last couple of years the Gross Margin of MCHX has grown nicely.
MCHX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.85%
GM growth 5Y5.7%

4

2. Health

2.1 Basic Checks

MCHX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MCHX has been increased compared to 1 year ago.
The number of shares outstanding for MCHX has been increased compared to 5 years ago.
Compared to 1 year ago, MCHX has a worse debt to assets ratio.

2.2 Solvency

MCHX has an Altman-Z score of -5.67. This is a bad value and indicates that MCHX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.67, MCHX is doing worse than 88.42% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that MCHX is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.01, MCHX is doing good in the industry, outperforming 78.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -5.67
ROIC/WACCN/A
WACC9.04%

2.3 Liquidity

A Current Ratio of 2.49 indicates that MCHX has no problem at all paying its short term obligations.
The Current ratio of MCHX (2.49) is better than 76.84% of its industry peers.
MCHX has a Quick Ratio of 2.49. This indicates that MCHX is financially healthy and has no problem in meeting its short term obligations.
MCHX has a Quick ratio of 2.49. This is in the better half of the industry: MCHX outperforms 76.84% of its industry peers.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 2.49

3

3. Growth

3.1 Past

MCHX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 60.00%, which is quite impressive.
MCHX shows a decrease in Revenue. In the last year, the revenue decreased by -3.81%.
MCHX shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.16% yearly.
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q75%
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y-0.85%
Revenue growth 5Y-10.16%
Revenue growth Q2Q-5.26%

3.2 Future

Based on estimates for the next years, MCHX will show a very strong growth in Earnings Per Share. The EPS will grow by 47.31% on average per year.
Based on estimates for the next years, MCHX will show a small growth in Revenue. The Revenue will grow by 4.05% on average per year.
EPS Next Y74.5%
EPS Next 2Y47.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.23%
Revenue Next 2Y4.05%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MCHX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 65.69, MCHX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, MCHX is valued a bit more expensive than the industry average as 62.11% of the companies are valued more cheaply.
When comparing the Price/Forward Earnings ratio of MCHX to the average of the S&P500 Index (20.15), we can say MCHX is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 65.69

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MCHX's earnings are expected to grow with 47.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.31%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MCHX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MARCHEX INC-CLASS B

NASDAQ:MCHX (5/17/2024, 7:12:19 PM)

1.34

+0.04 (+3.08%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap58.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 65.69
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.1%
ROE -19.75%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 60.25%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.49
Quick Ratio 2.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y74.5%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.81%
Revenue growth 3Y-0.85%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y